Completed PHASE2 INTERVENTIONAL 2-arm NCT04745442

Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19

Sponsor: Maimónides Biomedical Research Institute of Córdoba

Conditions Covid19 Distress Respiratory Syndrome Severe Acute Respiratory Syndrome

Interventions Antithrombin + best available treatment Best available treatment

Updated 3 times since 2021 Last updated: Feb 8, 2021 Started: Apr 27, 2020 Primary completion: Dec 20, 2020 Completion: Jan 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Covid19 and Distress Respiratory Syndrome and is currently completed. Maimónides Biomedical Research Institute of Córdoba leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2021 — Jul 2024 [monthly]

Completed PHASE2

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maimónides Biomedical Research Institute of Córdoba

Data source: Maimónides Biomedical Research Institute of Córdoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Córdoba, Spain